Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
H&R GmbH KGaAXTER:2HRA -2.14%66 Days Payable is 35.95 as of Mar. 2026, which is 1% below its 10-year median of 36.36. GuruFocus rates XTER:2HRA with a GF Score™ of 66/100 and a GF Value™ of €4.21 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,554 Chemicals companies, H&R GmbH KGaA ranks worse than 75.29% on this metric.
The historical rank and industry rank for H&R GmbH KGaA's Days Payable or its related term are showing as below:
XTER:2HRA'
s Days Payable Range Over the Past 10 Years
Min: 28.62 Med: 36.36 Max: 52.35
Current: 34.76
During the past 13 years, H&R GmbH KGaA's highest Days Payable was 52.35. The lowest was 28.62. And the median was 36.36.
XTER:2HRA's Days Payable is ranked worse than 75.29% of 1554
companies
in the Chemicals industry
Industry Median: 59.73
vs XTER:2HRA: 34.76
H&R GmbH KGaA's Days Payable
increased
from Mar. 2025 (28.98) to Mar. 2026 (35.95).
It may suggest that H&R GmbH KGaAdelayed paying its suppliers.
H&R GmbH KGaA Days Payable Related Terms
H&R GmbH KGaA Days Payable Historical Data
* Premium members only.
The historical data trend for H&R GmbH KGaA's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:2HRA vs LIN, SHW, ECL: Days Payable Comparison
For the Specialty Chemicals subindustry, H&R GmbH KGaA's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H&R GmbH KGaA Days Payable vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, H&R GmbH KGaA's Days Payable distribution charts can be found below:
* The bar in red indicates where H&R GmbH KGaA's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
H&R GmbH KGaA's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H&R GmbH KGaA (XTER:2HRA) has a Days Payable of 35.95 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on H&R GmbH KGaA and its competitors. This is near median its historical median of 36.36. Over the past decade, H&R GmbH KGaA's Days Payable has ranged from 28.62 to 52.35. According to the industry distribution chart, H&R GmbH KGaA ranks #1170 out of 1554 companies in the Chemicals industry, placing it in the top 75.3%.
Is H&R GmbH KGaA's Days Payable too high?
H&R GmbH KGaA's current Days Payable of 35.95 is near median its 10-year median of 36.36. Over the past 10 years, this metric has ranged from a low of 28.62 to a high of 52.35. The Chemicals industry median Days Payable is 59.73. H&R GmbH KGaA's value of 35.95 is 39.8% below this industry median. Based on the distribution chart, H&R GmbH KGaA ranks #1170 out of 1554 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, H&R GmbH KGaA has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H&R GmbH KGaA's Days Payable compare to LIN and SHW?
According to the Chemicals industry distribution chart, H&R GmbH KGaA ranks #1170 out of 1554 companies for Days Payable. This places H&R GmbH KGaA in the lower half of its industry. The industry median Days Payable is 59.73. H&R GmbH KGaA's value of 35.95 is 39.8% below this benchmark. Historically, H&R GmbH KGaA's own Days Payable has ranged from 28.62 to 52.35 over the past decade. While the company's 10-year median is 36.36 vs. the industry median of 59.73, H&R GmbH KGaA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Chemicals company?
The median Days Payable among Chemicals companies is 59.73, based on 1,554 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. H&R GmbH KGaA's current Days Payable of 35.95 is 39.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on H&R GmbH KGaA and its competitors. For the Chemicals industry, the median Days Payable is 59.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. H&R GmbH KGaA's current Days Payable is 35.95, which is near median its own 10-year median of 36.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H&R GmbH KGaA stock overvalued right now?
Based on GuruFocus' analysis, H&R GmbH KGaA (XTER:2HRA) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.21, compared to a current price of €6.40 — trading 52% above its estimated fair value. The current Days Payable is 35.95, which is near median its 10-year median of 36.36 and 39.8% below the Chemicals industry median of 59.73. H&R GmbH KGaA's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For H&R GmbH KGaA (XTER:2HRA), the current Days Payable is 35.95 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H&R GmbH KGaA (XTER:2HRA) Overvalued in 2026?
Based on GuruFocus' analysis, H&R GmbH KGaA stock appears to be overvalued.
The current stock price of €6.40 is trading 52% above its estimated GF Value™ of €4.21.
GuruFocus considers H&R GmbH KGaA to be Significantly Overvalued.
Key valuation signals for XTER:2HRA:
Days Payable: 35.95 (near median its 10-year median of 36.36)
GF Value™: €4.21 vs. price of €6.40 (52% above fair value)
Industry Position: 39.8% below the Chemicals median (#1170 of 1554)
No single metric tells the full story. See the XTER:2HRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
H&R GmbH & Co KGaA is a manufacturer of chemical-pharmaceutical specialty products. The company organizes its operating activities into two business divisions: Chemical-Pharmaceutical Raw Materials and Plastics. It also has three business segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment produces specialty products from crude oil in the two domestic refineries (Hamburg-Neuhof and Salzbergen). Its ChemPharm Sales segment encompasses the production sites abroad as well as international sales activities. The company's Plastics segment manufactures high-precision plastic parts along with the associated tools and molds. The company derives a majority of its revenue from the ChemPharm Refining segment. Geographically, it derives key revenue from Germany.
66GF Score
Get the complete analysis for XTER:2HRA
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:2HRA has been successfully added to your 
